疼痛管理デバイス市場：種類別（神経刺激、SCS、TENS、RFアブレーション、インフュージョンポンプ）、用途別（ニューロパシー、がん、顔面、MSK、片頭痛）、購入形態別（OTC、処方箋ベース）、地域別（NA、欧州、APAC） - 2026年までの世界予測

Pain Management Devices Market by Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Neuropathy, Cancer, Facial, MSK, Migraine), Mode of Purchase (OTC, Prescription-based) & Region (NA, Europe, APAC) - Global Forecasts to 2026

疼痛管理機器の世界市場は、2021年の22億米ドルから2026年には33億米ドルに達すると予測され、予測期間中のCAGRは8.6%となります。疼痛管理機器は、がん、神経疾患、筋骨格系疾患など、さまざまな種類の疾患に苦... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2021年11月12日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	245	242	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

疼痛管理機器の世界市場は、2021年の22億米ドルから2026年には33億米ドルに達すると予測され、予測期間中のCAGRは8.6%となります。疼痛管理機器は、がん、神経疾患、筋骨格系疾患など、さまざまな種類の疾患に苦しむ患者の慢性および急性の疼痛を管理するために使用されます。これらのデバイスは、日常生活を送る能力を回復させ、経口鎮痛剤の必要性を減らし、これらの疾患に苦しむ患者の生活の質を向上させます。しかし、製品のリコールや治療費の高騰などにより、今後数年間の市場成長は難しいと考えられます。

神経刺激装置が市場の最大セグメントを占める
疼痛管理機器市場は、タイプ別に、神経刺激装置、輸液ポンプ、アブレーション装置に分けられます。2020年には、神経刺激装置が疼痛管理装置市場の58.0%を占めました。神経刺激装置は、脊髄と脳の間を伝わる痛みの信号を遮断することで、痛みを軽減します。これらのデバイスには、埋め込み型と非埋め込み型があります。神経刺激装置はさらに、経皮的電気神経刺激装置（TENS）と脊髄刺激装置に分類されます。このセグメントの大きなシェアと高い成長率は、慢性疼痛の管理における代替療法と比較した場合の神経調節の利点、長期的な費用対効果、および神経刺激装置セグメントにおける技術開発によるものです。

神経障害性疼痛がアプリケーション市場で最大のシェアを占める
疼痛管理デバイス市場は、アプリケーションに基づいて、神経因性疼痛、筋骨格系の疼痛、癌性疼痛、顔面痛・偏頭痛、その他のアプリケーションに分類されます。2020年には、神経障害性疼痛分野が31.4%と最大の市場シェアを占めています。神経障害性疼痛治療における疼痛管理機器の高い有効性を示す臨床証拠の存在、新規の神経障害性疼痛管理機器の開発、世界的な高齢化の進展（多くの加齢関連疾患に伴う神経障害性疼痛の発生率の上昇により、老人人口は神経障害性疼痛のリスクが高い）、神経障害性疼痛治療に使用される薬剤の副作用、償還制度の利用可能性が神経障害性疼痛治療への疼痛管理機器の導入を促進していることなどが、神経障害性疼痛用途向けの疼痛管理機器市場の成長に寄与する主な要因となっています。

北米の疼痛管理デバイス市場は米国が独占
2020年の疼痛管理デバイス市場では、北米が52.3%のシェアを占め、欧州・アジア太平洋地域、ラテンアメリカ、中東・アフリカと続きます。北米は、ヘルスケア業界における疼痛管理デバイスのサービス開発において、先進的な取り組みを行っています。米国の疼痛管理機器市場は、外来診療所での疼痛管理機器の導入が進んでいることから、今後数年間で成長の機会を得ることが期待されています。また、米国には多くの大手グローバル企業が拠点を置いており、疼痛管理デバイス市場におけるイノベーションの中心地となっています。

サプライサイドのプライマリーインタビューの内訳です。- 企業タイプ別。企業タイプ別：Tier1 - 60％、Tier2 - 30％、Tier3 - 10％ - デレクション別企業タイプ別：Tier1～60％、Tier2～30％、Tier3～10％、役職別：Directorレベル～30％、Cレベル～50％、その他～20％、地域別地域別：北米-45％、欧州-15％、APAC-25％、その他の地域-15
疼痛管理デバイス市場で活動している著名なプレーヤーとしては、Medtronic PLC（アイルランド）、Boston Scientific（米国）、Abbott（米国）、Becton, Dickinson and Company（米国）、Baxter International（米国）、B. Braun Melsungen AG（ドイツ）、Stryker（米国）、Smiths Medical（米国）、Moog Inc.(米)、Avanos Medical, Inc.(米)、ニプロ株式会社(日本)、Atricure(米)、Nevro Corp.(米国)、Micrel Medical Devices SA(ギリシャ)、InfuTronix Solutions LLC(米国)、Teleflex, Inc.(米国)、Mindray Medical International Limited(中国)、Shenzhen MedRena Biotech Co.(中国)、Epic Medical(シンガポール)、Bioness(米国)、Microtransponder(米国)、Neuronano(スウェーデン)、Gimer Medical(台湾)、Bluewind Medical(イスラエル)、Soterix Medical Inc.(米国)などがあります。

調査範囲
本レポートでは、疼痛管理デバイス市場をタイプ別、購入形態別、用途別、地域別に調査しています。また、市場の成長に影響を与える要因（推進要因、阻害要因、機会、課題など）を調査しています。市場における機会と課題を分析し、市場リーダーの競争環境の詳細を提供しています。さらに、個別の成長トレンドに関してミクロ市場を分析し、ソースとデスティネーションという2つの主要地域に関して市場セグメントの収益を予測しています。

このレポートを購入する主なメリット
本レポートでは、様々なレベルの分析-業界動向、トッププレイヤーの市場シェア、企業プロファイルに焦点を当て、これらを合わせて基本的な見解を形成し、競合環境、高成長地域とそのドライバー、抑制、課題、機会を分析しています。本レポートは、既存の企業だけでなく、新規参入者や小規模な企業が市場の動向を把握し、より大きなシェアを獲得するために役立ちます。

ページTOPに戻る

Table of Contents

Summary

The global pain management devices market is projected to reach USD 3.3 billion by 2026 from USD 2.2 billion in 2021, at a CAGR of 8.6% during the forecast period Pain management devices are used to manage chronic and acute pain in patients suffering from various types of disease conditions, such as cancer, neurological disorders, and musculoskeletal disorders, among others. These devices restore the ability to do everyday activities, decrease the need for oral pain medications, and improve the quality of life of patients suffering from these conditions. However, product recalls and high procedural costs likely to challenge market growth in the coming years.

Neurostimulation devices to hold the largest segment of the market
Based on type, the pain management devices market is segmented into neurostimulation devices, infusion pumps, and ablation devices. In 2020, the neurostimulation segment accounted for 58.0% of the pain management devices market. Neurostimulation devices provide pain relief by disrupting pain signals traveling between the spinal cord and the brain. These devices can be either implantable or non-implantable in nature. Neuromodulation devices are further classified into transcutaneous electrical nerve stimulators (TENS) and spinal cord stimulators. The large share and high growth of this segment is attributed to advantages of neuromodulation as compared to alternative therapies for managing chronic pain, its long-term cost effectivity and technological developments in the neurostimulation devices segment.

Neuropathic pain to hold the largest share of the applications market
Based on application, the pain management devices market is segmented into neuropathic pain, musculoskeletal pain, cancer pain, facial pain & migraine, and other applications. The neuropathic pain segment accounted for the largest market share of 31.4% in 2020. The presence of substantial clinical evidences in the favor of high efficacy of pain management devices in neuropathic pain treatment, development of novel neuropathic pain management devices, rising aging population across the globe (geriatric population is at high risk of neuropathic pain due to the increased incidence of neuropathic pain associated with many age-related diseases), side effects of drugs used to treat neuropathic pain, and availability of reimbursement are fueling the adoption of pain management devices for neuropathic pain treatment are the major factors contributing to the growth of the pain management devices market for neuropathic pain applications.

The US to dominate the pain management devices market in North America
North America dominated the pain management devices market, with a share of 52.3% in 2020, followed by Europe and the Asia Pacific, Latin America, and Middle East & Africa. North America has been among the frontrunners in developing pain management devices services in the healthcare industry. The pain management devices market in the US is expected to offer growth opportunities in the coming years owing to the increasing adoption of pain management devices in ambulatory care centers. Many major global players are also based in the US, owing to which the country has become a center of innovation in the pain management devices market.

Breakdown of supply-side primary interviews: • By Company Type: Tier 1 – 60%, Tier 2 – 30%, and Tier 3 – 10% • By Designation: Director-level – 30%, C-level – 50%, and Others – 20% • By Region: North America - 45%, Europe – 15%, APAC –25%, Rest of the World –15%
Some of the prominent players operating in the pain management devices market are Medtronic PLC (Ireland), Boston Scientific (US), Abbott (US), Becton, Dickinson and Company (US), Baxter International (US), B. Braun Melsungen AG (Germany), Stryker (US), Smiths Medical (US), Moog Inc. (US), Avanos Medical, Inc. (US), Nipro Corporation (Japan), Atricure (US), Nevro Corp. (US), Micrel Medical Devices SA (Greece), InfuTronix Solutions LLC (US), Teleflex, Inc. (US), Mindray Medical International Limited (China), Shenzhen MedRena Biotech Co., Ltd. (China), Epic Medical (Singapore), Bioness (US), Microtransponder (US), Neuronano (Sweden), Gimer Medical (Taiwan), Bluewind Medical (Israel), Soterix Medical Inc. (US) and other players.

Research Coverage
This report studies the pain management devices market based on type, mode of purchase, and application, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to two main geographies – source and destination.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

ページTOPに戻る

1 INTRODUCTION 30

1.1 OBJECTIVES OF THE STUDY 30

1.2 MARKET DEFINITION 30

1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 31

1.3 MARKET SCOPE 31

1.3.1 MARKETS COVERED 31

1.3.2 YEARS CONSIDERED FOR THE STUDY 32

1.3.3 CURRENCY 32

1.4 STAKEHOLDERS 33

1.5 SUMMARY OF CHANGES 33

2 RESEARCH METHODOLOGY 35

2.1 RESEARCH APPROACH 35

2.2 RESEARCH METHODOLOGY DESIGN 35

FIGURE 1 PAIN MANAGEMENT DEVICES MARKET: RESEARCH DESIGN 35

2.2.1 SECONDARY RESEARCH 36

2.2.1.1 Key data from secondary sources 37

2.2.2 PRIMARY DATA 38

FIGURE 2 PRIMARY SOURCES 38

2.2.2.1 Key data from primary sources 39

2.2.2.2 Key industry insights 39

FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 40

FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 40

2.3 MARKET SIZE ESTIMATION 41

FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 41

FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC PLC 42

FIGURE 7 REVENUE ANALYSIS OF THE TOP FIVE COMPANIES: PAIN MANAGEMENT DEVICES MARKET (2020) 43

FIGURE 8 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE PAIN MANAGEMENT DEVICES MARKET (2021–2026) 45

FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 45

FIGURE 10 TOP-DOWN APPROACH 46

2.4 MARKET BREAKDOWN & DATA TRIANGULATION 47

FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY 47

2.5 MARKET SHARE ANALYSIS 48

2.6 ASSUMPTIONS FOR THE STUDY 48

2.7 RISK ASSESSMENT 49

TABLE 1 RISK ASSESSMENT: PAIN MANAGEMENT DEVICES MARKET 49

2.8 LIMITATIONS 49

2.8.1 METHODOLOGY-RELATED LIMITATIONS 49

2.8.2 SCOPE-RELATED LIMITATIONS 49

3 EXECUTIVE SUMMARY 50

FIGURE 12 PAIN MANAGEMENT DEVICES MARKET, BY TYPE,

2021 VS. 2026 (USD MILLION) 50

FIGURE 13 NEUROSTIMULATION MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 51

FIGURE 14 INFUSION PUMP MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 51

FIGURE 15 ABLATION DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 52

FIGURE 16 PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION,

2021 VS. 2026 (USD MILLION) 52

FIGURE 17 PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE,

2021 VS. 2026 (USD MILLION) 53

FIGURE 18 GEOGRAPHIC SNAPSHOT: INFUSION PUMPS MARKET 54

4 PREMIUM INSIGHTS 56

4.1 PAIN MANAGEMENT DEVICES MARKET OVERVIEW 56

FIGURE 19 GROWING DEMAND FOR LONG-TERM PAIN MANAGEMENT AMONG THE GERIATRIC POPULATION—PRIMARY MARKET DRIVER 56

4.2 ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET SHARE, BY APPLICATION & REGION (2020) 57

FIGURE 20 NEUROSTIMULATION TO HOLD THE LARGEST SHARE OF THE ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET IN 2020 57

4.3 PAIN MANAGEMENT DEVICES MARKET: GEOGRAPHIC MIX 58

FIGURE 21 THE US TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 58

4.4 REGIONAL MIX: PAIN MANAGEMENT DEVICES MARKET 59

FIGURE 22 NORTH AMERICA DOMINATED THE MARKET IN 2020 59

5 MARKET OVERVIEW 60

5.1 INTRODUCTION 60

5.2 MARKET DYNAMICS 60

FIGURE 23 PAIN MANAGEMENT DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 60

5.2.1 MARKET DRIVERS 61

5.2.1.1 Rising demand for chronic pain management in home care settings 61

5.2.1.2 Growing number of surgical procedures performed 61

5.2.1.3 Rising prevalence of neurological disorders 62

5.2.1.3.1 Growing incidence of sports injuries and cancer 62

TABLE 2 COUNTRY-WISE CANCER INCIDENCE PER MILLION POPULATION, 2015–2019 63

5.2.1.4 Established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries 63

5.2.2 MARKET RESTRAINTS 64

5.2.2.1 Product recalls 64

5.2.2.2 High procedural and purchase cost of pain management devices 64

5.2.3 MARKET OPPORTUNITIES 65

5.2.3.1 High growth opportunities in emerging countries 65

TABLE 3 RISING INCOME LEVELS IN EMERGING COUNTRIES 65

5.2.3.2 Expanding base of pain management clinics/centers across the globe 66

5.2.3.3 Use of pain medications as the first line of treatment for pain management 66

5.2.3.4 Stringent regulatory guidelines delay the adoption of novel devices 67

TABLE 4 PRESENCE OF ALTERNATIVE THERAPIES FOR PAIN MANAGEMENT IS A MAJOR MARKET CHALLENGE 67

5.3 REGULATORY LANDSCAPE 68

TABLE 5 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING PAIN MANAGEMENT DEVICES 68

5.3.1 NORTH AMERICA 69

5.3.1.1 US 69

TABLE 6 US FDA: MEDICAL DEVICE CLASSIFICATION 69

TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 69

FIGURE 24 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES 70

5.3.1.2 Canada 70

FIGURE 25 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 71

5.3.2 EUROPE 72

FIGURE 26 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES 73

5.3.3 ASIA PACIFIC 74

5.3.3.1 Japan 74

TABLE 9 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA) 74

5.3.3.2 China 74

TABLE 10 CHINA: CLASSIFICATION OF MEDICAL DEVICES 75

5.3.3.3 India 76

FIGURE 27 LATIN AMERICA: REGULATORY SCENARIO 77

5.3.3.4 Brazil 77

FIGURE 28 BRAZIL: REGULATORY PROCESS FOR MEDICAL DEVICES 78

TABLE 11 BRAZIL: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 78

5.3.3.5 Mexico 79

FIGURE 29 MEXICO: REGULATORY PROCESS FOR MEDICAL DEVICES 79

TABLE 12 MEXICO: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS 80

5.4 VALUE CHAIN ANALYSIS 80

FIGURE 30 PAIN MANAGEMENT DEVICES MARKET: VALUE CHAIN ANALYSIS 81

5.5 SUPPLY CHAIN ANALYSIS 81

FIGURE 31 PAIN MANAGEMENT DEVICES MARKET: SUPPLY CHAIN ANALYSIS 82

5.6 PORTER’S FIVE FORCES ANALYSIS 83

TABLE 13 PORTER’S FIVE FORCES ANALYSIS 83

5.6.1 THREAT FROM NEW ENTRANTS 84

5.6.2 THREAT FROM SUBSTITUTES 84

5.6.3 BARGAINING POWER OF SUPPLIERS 84

5.6.4 BARGAINING POWER OF BUYERS 85

5.6.5 COMPETITIVE RIVALRY 85

5.7 INDUSTRY TRENDS 85

5.7.1 WEARABLE DEVICES 85

5.7.2 RISING POPULARITY OF RECHARGEABLE SPINAL CORD STIMULATORS 85

5.8 TRADE ANALYSIS 86

5.8.1 TRADE ANALYSIS FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES 86

TABLE 14 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY,

2016–2020 (USD BILLION) 86

5.9 COVID-19 IMPACT ON THE PAIN MANAGEMENT DEVICES MARKET 86

6 PAIN MANAGEMENT DEVICES MARKET, BY TYPE 88

6.1 INTRODUCTION 89

TABLE 15 PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 89

6.2 NEUROSTIMULATION DEVICES 89

TABLE 16 NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 90

TABLE 17 NEUROSTIMULATION DEVICES MARKET, BY REGION,

2019–2026 (USD MILLION) 90

6.2.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) DEVICES 90

6.2.1.1 Extensive use in healthcare, low cost, and ease of use will favor market growth 90

TABLE 18 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION) 91

6.2.2 SPINAL CORD STIMULATION 91

6.2.2.1 Rising incidence of indications and efficacy & reversibility of procedure have supported the adoption of SCS 91

TABLE 19 SPINAL CORD STIMULATION DEVICES MARKET SIZE, BY REGION,

2019–2026 (USD MILLION) 92

6.3 INFUSION PUMPS 92

6.3.1 HIGH USE OF INFUSION PUMPS IN POSTOPERATIVE PAIN MANAGEMENT 92

TABLE 20 INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 93

TABLE 21 INFUSION PUMPS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION) 93

6.3.2 INTRATHECAL INFUSION PUMPS 93

TABLE 22 INTRATHECAL INFUSION PUMPS DEVICES MARKET SIZE, BY REGION,

2019–2026 (USD MILLION) 94

6.3.3 EXTERNAL INFUSION PUMPS 94

TABLE 23 EXTERNAL INFUSION PUMPS DEVICES MARKET SIZE, BY REGION,

2019–2026 (USD MILLION) 95

6.4 ABLATION DEVICES 95

TABLE 24 ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 95

TABLE 25 ABLATION DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION) 96

6.4.1 RF ABLATION DEVICES 96

TABLE 26 RF ABLATION DEVICES MARKET SIZE, BY REGION,

2019–2026 (USD MILLION) 97

6.4.2 CRYOABLATION DEVICES 97

TABLE 27 CRYOABLATION DEVICES MARKET SIZE, BY REGION,

2019–2026 (USD MILLION) 98

7 PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION 99

7.1 INTRODUCTION 100

TABLE 28 PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,

2019–2026 (USD MILLION) 100

7.2 NEUROPATHIC PAIN 100

7.2.1 HIGH PREVALENCE OF DISEASES ASSOCIATED WITH NEUROPATHIC PAIN 100

TABLE 29 NEUROPATHIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION) 101

7.3 CANCER PAIN 101

TABLE 30 CANCER PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION,

2019–2026 (USD MILLION) 102

7.4 FACIAL PAIN & MIGRAINE 102

TABLE 31 FACIAL PAIN & MIGRAINE MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION) 104

7.5 MUSCULOSKELETAL PAIN 104

TABLE 32 MUSCULOSKELETAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION) 105

7.6 OTHER APPLICATIONS 105

TABLE 33 OTHER PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION,

2019–2026 (USD MILLION) 106

8 PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE 107

8.1 INTRODUCTION 108

TABLE 34 PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE,

2019–2026 (USD MILLION) 108

8.2 OVER-THE-COUNTER PAIN MANAGEMENT DEVICES 108

8.2.1 OTC PAIN MANAGEMENT DEVICES UNFOLD NEW GROWTH AVENUES 108

TABLE 35 OVER-THE-COUNTER PAIN MANAGEMENT DEVICES MARKET SIZE,

BY REGION, 2019–2026 (USD MILLION) 109

8.3 PRESCRIPTION-BASED PAIN MANAGEMENT DEVICES 109

TABLE 36 PRESCRIPTION-BASED PAIN MANAGEMENT DEVICES MARKET SIZE,

BY REGION, 2019–2026 (USD MILLION) 110

9 PAIN MANAGEMENT DEVICES MARKET, BY REGION 111

9.1 INTRODUCTION 112

FIGURE 32 PAIN MANAGEMENT DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 112

TABLE 37 GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION,

2019–2026 (USD MILLION) 113

9.2 NORTH AMERICA 113

FIGURE 33 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SNAPSHOT 114

TABLE 38 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION) 114

TABLE 39 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 115

TABLE 40 NORTH AMERICA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 115

TABLE 41 NORTH AMERICA: INFUSION PUMPS MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 115

TABLE 42 NORTH AMERICA: ABLATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 116

TABLE 43 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE,

BY APPLICATION, 2019–2026 (USD MILLION) 116

TABLE 44 NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE,

BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 116

9.2.1 THE US 117

9.2.1.1 The US is expected to hold the leading position in the market due to the rising geriatric population, increasing prevalence of chronic diseases, and the growing home healthcare market 117

TABLE 45 KEY MACROINDICATORS FOR THE US 117

TABLE 46 US: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 118

TABLE 47 US: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 118

TABLE 48 US: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 118

TABLE 49 US: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 119

TABLE 50 US: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,

2019–2026 (USD MILLION) 119

TABLE 51 US: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 119

9.2.2 CANADA 120

9.2.2.1 Increasing incidence of chronic pain indications to support the adoption of pain management devices in Canada 120

TABLE 52 KEY MACROINDICATORS FOR CANADA 120

TABLE 53 CANADA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 121

TABLE 54 CANADA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 121

TABLE 55 CANADA: INFUSION PUMPS MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 121

TABLE 56 CANADA: ABLATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 122

TABLE 57 CANADA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION) 122

TABLE 58 CANADA: PAIN MANAGEMENT DEVICES MARKET SIZE,

BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 122

9.3 EUROPE 123

TABLE 59 EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY,

2019–2026 (USD MILLION) 124

TABLE 60 EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 124

TABLE 61 EUROPE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 125

TABLE 62 EUROPE: INFUSION PUMPS MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 125

TABLE 63 EUROPE: ABLATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 125

TABLE 64 EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION) 126

TABLE 65 EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE,

BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 126

9.3.1 GERMANY 126

9.3.1.1 Presence of leading pain management device manufacturers to drive market growth in Germany 126

TABLE 66 KEY MACROINDICATORS FOR GERMANY 127

TABLE 67 GERMANY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 128

TABLE 68 GERMANY: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 128

TABLE 69 GERMANY: INFUSION PUMPS MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 128

TABLE 70 GERMANY: ABLATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 129

TABLE 71 GERMANY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION) 129

TABLE 72 GERMANY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 129

9.3.2 FRANCE 130

TABLE 73 KEY MACROINDICATORS FOR FRANCE 130

TABLE 74 FRANCE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 131

TABLE 75 FRANCE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 131

TABLE 76 FRANCE: INFUSION PUMPS MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 131

TABLE 77 FRANCE: ABLATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 132

TABLE 78 FRANCE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION) 132

TABLE 79 FRANCE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 132

9.3.3 THE UK 133

9.3.3.1 High burden of chronic pain in the country to propel the

growth of the pain management devices market 133

TABLE 80 KEY MACROINDICATORS FOR THE UK 134

TABLE 81 UK: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 134

TABLE 82 UK: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 134

TABLE 83 UK: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 135

TABLE 84 UK: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 135

TABLE 85 UK: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,

2019–2026 (USD MILLION) 135

TABLE 86 UK: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 136

9.3.4 ITALY 136

9.3.4.1 Growing demand for cost-effective home care services to support market growth 136

TABLE 87 KEY MACROINDICATORS FOR ITALY 136

TABLE 88 ITALY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 137

TABLE 89 ITALY: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 137

TABLE 90 ITALY: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 138

TABLE 91 ITALY: ABLATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 138

TABLE 92 ITALY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,

2019–2026 (USD MILLION) 138

TABLE 93 ITALY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 139

9.3.5 SPAIN 139

9.3.5.1 Rising prevalence of cancer to support the market for pain management devices market in Spain 139

TABLE 94 KEY MACROINDICATORS FOR SPAIN 140

TABLE 95 SPAIN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 140

TABLE 96 SPAIN: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 140

TABLE 97 SPAIN: INFUSION PUMPS MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 141

TABLE 98 SPAIN: ABLATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 141

TABLE 99 SPAIN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,

2019–2026 (USD MILLION) 141

TABLE 100 SPAIN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 142

9.3.6 REST OF EUROPE 142

TABLE 101 ROE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 143

TABLE 102 ROE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 143

TABLE 103 ROE: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 143

TABLE 104 ROE: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 144

TABLE 105 ROE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,

2019–2026 (USD MILLION) 144

TABLE 106 ROE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 144

9.4 ASIA PACIFIC 145

FIGURE 34 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SNAPSHOT 146

TABLE 107 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION) 147

TABLE 108 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 147

TABLE 109 ASIA PACIFIC: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 147

TABLE 110 ASIA PACIFIC: INFUSION PUMPS MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 148

TABLE 111 ASIA PACIFIC: ABLATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 148

TABLE 112 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION) 148

TABLE 113 ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE,

BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 149

9.4.1 JAPAN 149

9.4.1.1 Large geriatric population in the country is driving the demand for infusion pumps 149

TABLE 114 KEY MACRO INDICATORS FOR JAPAN 150

TABLE 115 JAPAN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 150

TABLE 116 JAPAN: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 150

TABLE 117 JAPAN: INFUSION PUMPS MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 151

TABLE 118 JAPAN: ABLATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 151

TABLE 119 JAPAN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,

2019–2026 (USD MILLION) 151

TABLE 120 JAPAN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 152

9.4.2 CHINA 152

9.4.2.1 Growing investments in healthcare infrastructure development in the country to drive market growth in China 152

TABLE 121 KEY MACRO INDICATORS FOR CHINA 153

TABLE 122 CHINA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 153

TABLE 123 CHINA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 153

TABLE 124 CHINA: INFUSION PUMPS MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 154

TABLE 125 CHINA: ABLATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 154

TABLE 126 CHINA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,

2019–2026 (USD MILLION) 154

TABLE 127 CHINA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 155

9.4.3 INDIA 155

9.4.3.1 High prevalence of lifestyle diseases in the country to drive the market for pain management devices market 155

TABLE 128 KEY MACRO INDICATORS FOR INDIA 156

TABLE 129 INDIA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 156

TABLE 130 INDIA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 156

TABLE 131 INDIA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 157

TABLE 132 INDIA: ABLATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 157

TABLE 133 INDIA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,

2019–2026 (USD MILLION) 157

TABLE 134 INDIA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 158

9.4.4 REST OF ASIA PACIFIC 158

9.4.4.1 High prevalence of chronic diseases in the region to drive the market for pain management devices 158

FIGURE 35 PREVALENCE OF DIABETES IN SOUTHEAST ASIA (2018/2019) 159

TABLE 135 ESTIMATED NUMBER OF CANCER CASES IN SOUTHEAST ASIAN COUNTRIES, 2020 VS. 2040 (IN THOUSAND) 159

FIGURE 36 HEALTHCARE EXPENDITURE (% GDP) IN SOUTHEAST ASIA (2018) 159

FIGURE 37 GERIATRIC POPULATION IN 2019 (% OF TOTAL POPULATION) 160

TABLE 136 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 160

TABLE 137 REST OF ASIA PACIFIC: NEUROSTIMULATION DEVICES MARKET SIZE,

BY TYPE, 2019–2026 (USD MILLION) 160

TABLE 138 REST OF ASIA PACIFIC: INFUSION PUMPS MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 161

TABLE 139 REST OF ASIA PACIFIC: ABLATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 161

TABLE 140 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE,

BY APPLICATION, 2019–2026 (USD MILLION) 161

TABLE 141 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE,

BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 162

9.5 LATIN AMERICA 162

TABLE 142 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 163

TABLE 143 LATIN AMERICA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION) 163

TABLE 144 LATIN AMERICA: INFUSION PUMPS MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 163

TABLE 145 LATIN AMERICA: ABLATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 164

TABLE 146 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE,

BY APPLICATION, 2019–2026 (USD MILLION) 164

TABLE 147 LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE,

BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 164

9.6 MIDDLE EAST AND AFRICA 165

9.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH 165

TABLE 148 MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET SIZE,

BY TYPE, 2019–2026 (USD MILLION) 165

TABLE 149 MIDDLE EAST & AFRICA: NEUROSTIMULATION DEVICES MARKET SIZE,

BY TYPE, 2019–2026 (USD MILLION) 166

TABLE 150 MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 166

TABLE 151 MIDDLE EAST & AFRICA: ABLATION DEVICES MARKET SIZE, BY TYPE,

2019–2026 (USD MILLION) 166

TABLE 152 MIDDLE EAST AND AFRICA: PAIN MANAGEMENT DEVICES MARKET SIZE,

BY APPLICATION, 2019–2026 (USD MILLION) 167

TABLE 153 MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET SIZE,

BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 167

10 COMPETITIVE LANDSCAPE 168

10.1 OVERVIEW 168

FIGURE 38 KEY DEVELOPMENTS OF PROMINENT PLAYERS OPERATING IN PAIN MANAGEMENT DEVICES MARKET (2020-2021) 169

10.2 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 170

FIGURE 39 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE PAIN MANAGEMENT DEVICES MARKET 170

10.3 MARKET SHARE ANALYSIS 170

FIGURE 40 PAIN MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2020 171

10.4 COMPANY EVALUATION QUADRANT 172

10.4.1 STARS 172

10.4.2 EMERGING LEADERS 172

10.4.3 PERVASIVE PLAYERS 172

10.4.4 PARTICIPANTS 173

FIGURE 41 PAIN MANAGEMENT DEVICES MARKET: COMPANY EVALUATION QUADRANT (2020) 173

10.5 COMPANY EVALUATION QUADRANT FOR START-UPS 174

10.5.1 PROGRESSIVE COMPANIES 174

10.5.2 DYNAMIC COMPANIES 174

10.5.3 STARTING BLOCKS 174

10.5.4 RESPONSIVE COMPANIES 174

FIGURE 42 PAIN MANAGEMENT DEVICES MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS (2020) 175

10.6 COMPANY PRODUCT FOOTPRINT 176

TABLE 154 PRODUCT PORTFOLIO ANALYSIS: PAIN MANAGEMENT DEVICES MARKET 176

10.7 GEOGRAPHIC FOOTPRINT OF THE MAJOR PLAYERS IN THE PAIN MANAGEMENT DEVICES MARKET 177

TABLE 155 GEOGRAPHIC REVENUE MIX: PAIN MANAGEMENT DEVICES MARKET (2020) 177

10.8 COMPETITIVE SCENARIO 178

10.8.1 PRODUCT LAUNCHES 178

TABLE 156 PRODUCT LAUNCHES (JANUARY 2018 – JUNE 2021) 178

10.8.2 DEALS 181

TABLE 157 DEALS (JANUARY 2018–JUNE 2021) 181

10.8.3 OTHER DEVELOPMENTS 183

TABLE 158 OTHER DEVELOPMENTS (JANUARY 2018– JUNE 2021) 183

11 COMPANY PROFILES 184

11.1 KEY PLAYERS 184

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*

11.1.1 MEDTRONIC 184

TABLE 159 MEDTRONIC PLC: BUSINESS OVERVIEW 184

FIGURE 43 MEDTRONIC PLC: COMPANY SNAPSHOT (2020) 185

11.1.2 ABBOTT LABORATORIES 188

TABLE 160 ABBOTT LABORATORIES: BUSINESS OVERVIEW 188

FIGURE 44 ABBOTT LABORATORIES: COMPANY SNAPSHOT 188

TABLE 161 ABBOTT LABORATORIES: PRODUCT OFFERINGS 189

11.1.3 BOSTON SCIENTIFIC CORPORATION 191

TABLE 162 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 191

FIGURE 45 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 192

TABLE 163 BOSTON SCIENTIFIC CORPORATION: PRODUCT OFFERINGS 193

11.1.4 STRYKER CORPORATION 195

TABLE 164 STRYKER: BUSINESS OVERVIEW 195

FIGURE 46 STRYKER CORPORATION: COMPANY SNAPSHOT 196

TABLE 165 STRYKER: PRODUCT OFFERINGS 196

11.1.5 BECTON, DICKINSON AND COMPANY 198

TABLE 166 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 198

FIGURE 47 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020) 199

11.1.6 B. BRAUN MELSUNGEN AG 202

TABLE 167 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW 202

FIGURE 48 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020) 203

11.1.7 BAXTER INTERNATIONAL INC. 207

TABLE 168 BAXTER INTERNATIONAL INC.: BUSINESS OVERVIEW 207

FIGURE 49 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2020) 208

11.1.8 AVANOS MEDICAL, INC. 211

TABLE 169 AVANOS MEDICAL, INC.: BUSINESS OVERVIEW 211

FIGURE 50 AVANOS MEDICAL, INC.: COMPANY SNAPSHOT (2020) 212

11.1.9 TELEFLEX, INC. 214

TABLE 170 TELEFLEX, INC.: BUSINESS OVERVIEW 214

FIGURE 51 TELEFLEX, INC.: COMPANY SNAPSHOT (2020) 215

11.1.10 SMITHS MEDICAL 216

TABLE 171 SMITHS MEDICAL: BUSINESS OVERVIEW 216

FIGURE 52 SMITHS MEDICAL: COMPANY SNAPSHOT (2020) 217

11.1.11 NIPRO CORPORATION 219

TABLE 172 NIPRO CORPORATION: BUSINESS OVERVIEW 219

FIGURE 53 NIPRO CORPORATION: COMPANY SNAPSHOT (2019) 220

11.1.12 MOOG INC. 222

TABLE 173 MOOG INC.: BUSINESS OVERVIEW 222

FIGURE 54 MOOG INC.: COMPANY SNAPSHOT (2020) 223

11.1.13 ATRICURE 225

TABLE 174 ATRICURE: BUSINESS OVERVIEW 225

FIGURE 55 ATRICURE: COMPANY SNAPSHOT 225

TABLE 175 ATRICURE: PRODUCT OFFERINGS 226

11.1.14 NEVRO CORP. 227

TABLE 176 NEVRO CORP: BUSINESS OVERVIEW 227

FIGURE 56 NEVRO CORP.: COMPANY SNAPSHOT 227

TABLE 177 NEVRO CORP: PRODUCT OFFERINGS 228

11.1.15 MICREL MEDICAL DEVICES SA 229

TABLE 178 MICREL MEDICAL DEVICES SA: BUSINESS OVERVIEW 229

11.1.16 MINDRAY MEDICAL INTERNATIONAL LIMITED 231

TABLE 179 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW 231

11.1.17 SHENZHEN MEDRENA BIOTECH CO., LTD. 233

TABLE 180 SHENZHEN MEDRENA BIOTECH CO., LTD.: BUSINESS OVERVIEW 233

11.1.18 EPIC MEDICAL 234

TABLE 181 EPIC MEDICAL: BUSINESS OVERVIEW 234

11.1.19 BIONESS 235

11.1.20 SOTERIX MEDICAL 236

11.2 OTHER PLAYERS 237

11.2.1 INFUTRONIX SOLUTIONS LLC 237

TABLE 182 INFUTRONIX SOLUTIONS LLC: BUSINESS OVERVIEW 237

11.2.2 GIMER MEDICAL 239

11.2.3 BLUEWIND MEDICAL 239

11.2.4 NEURONANO 239

11.2.5 MICROTRANSPONDER 240

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX 241

12.1 DISCUSSION GUIDE 241

12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 245

12.3 AVAILABLE CUSTOMIZATIONS 247

12.4 RELATED REPORTS 248

12.5 AUTHOR DETAILS 249

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（cancer）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（cancer）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?